inserm UFRSMBH Logo UP13

2022

Wang P, Duchemann B, Chouahnia K, Matton L, Benabadji A, Zelek L, Popotte H, Paix A. La radiothérapie postopératoire dans les cancers non à petites cellules de stade IIIA – N2 : mise au point et perspectives [Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives]. Bull Cancer. 2022 Oct 11:S0007-4551(22)00348-4. French. doi: 10.1016/j.bulcan.2022.08.010. Epub ahead of print. PMID: 36241461.

Lasvergnas J, Naigeon M, Chouahnia K, Zelek L, Chaput N, Duchemann B. Adoptive cell therapies in thoracic malignancies. Cancer Immunol Immunother.2022 Sep;71(9):2077-2098. doi:10.1007/s00262-022-03142-3. Epub 2022 Feb 7.PMID: 35129636.

Sesé L, Mahay G, Barnig C, Guibert N, Leroy S, Guilleminault L. Marqueurs de sévérité et marqueurs prédictifs de réponse au traitement dans l’asthme sévère [Markers of severity and predictors of response to treatment in severe asthma]. Rev Mal Respir. 2022 Sep 14:S0761-8425(22)00285-6. French. doi: 10.1016/j.rmr.2022.08.009. Epub ahead of print. PMID: 36115752.

Kam M, Caliez J, Nunes H, Gille T. The road to hell is paved with good intentions: a look back at the PANTHER-IPF trial. Breathe ; 2022, 18 : 220074. doi:10.1183/20734735.0074-2022. PMID: 36340823.

Sève P, Jamilloux Y, Bert A, El Jammal T, Valeyre D. Qu’apportent les nouvelles recommandations sur le diagnostic et le traitement de la sarcoïdose ? [What do the recent recommendations for the diagnosis and treatment of sarcoidosis mean ?]. Rev Med Interne. 2022 Apr;43(4):199-205. French. doi: 10.1016/j.revmed.2022.02.006. Epub 2022 Mar 4. PMID: 35249763.

Tana C, Drent M, Nunes H, Kouranos V, Cinetto F, Jessurun NT, Spagnolo P. Comorbidities of sarcoidosis. Ann Med. 2022 Dec;54(1):1014-1035. doi: 10.1080/07853890.2022.2063375. PMID: 35441568.

Savale L, Huitema M, Shlobin O, Kouranos V, Nathan SD, Nunes H, Gupta R, Grutters JC, Culver DA, Post MC, Ouellette D, Lower EE, Al-Hakim T, Wells AU, Humbert M, Baughman RP. WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. Eur Respir Rev. 2022 Feb 9;31(163):210165. doi: 10.1183/16000617.0165-2021. PMID: 35140103.

Gille T, Sivapalan P, Kaltsakas G, Kolekar SB, Armstrong M, Tuffnell R, Evans RA, Vagheggini G, Degani-Costa LH, Vicente C, Das N, Poberezhets V, Rolland-Debord C, Bayat S, Vogiatzis I, Franssen FME, Pinnock H, Vanfleteren LEGW. ERS International Congress 2021: highlights from the Respiratory Clinical Care and Physiology Assembly. ERJ Open Res. 2022 May 23;8(2):00710-2021. doi: 10.1183/23120541.00710-2021. eCollection 2022 Apr. PMID: 35615417.

Guler SA, Cuevas-Ocaña S, Nasser M, Wuyts WA, Wijsenbeek MS, Froidure A, Bargagli E, Renzoni EA, Veltkamp M, Spagnolo P, Nunes H, McCarthy C, Molina-Molina M, Bonella F, Poletti V, Kreuter M, Antoniou KM, Moor CC. ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly. ERJ Open Res. 2022 May 23;8(2):00640-2021. doi: 10.1183/23120541.00640-2021. eCollection 2022 Apr. PMID: 35615418


HP

visuel hypoxie smbh2

sample

doc